New mem­ber of the super­vi­sory board

Ange­lika Lep­pert appoin­ted by the Board of Direc­tors of the Foun­da­tion for Stem Cell Rese­arch and Rege­ne­ra­tive Medi­cine as a new mem­ber of the Super­vi­sory Board of ISAR Bioscience.

The busi­ness eco­no­mist has been CFO of KUPANDO GmbH, a bio­phar­maceu­ti­cal com­pany dedi­ca­ted to the tre­at­ment of can­cer and infec­tious dise­a­ses, since the end of 2021. After stu­dy­ing busi­ness admi­nis­tra­tion at an inter­na­tio­nal level, she worked as a con­sul­tant at Roland Ber­ger. In 1999, she joi­ned Medi­Gene AG, where she mana­ged the pre­pa­ra­tion and exe­cu­tion of the IPO and sup­ported M&A tran­sac­tions. From 2006, she worked as a con­sul­tant in the areas of cor­po­rate finance, stra­tegy faci­li­ta­tion, orga­niza­tio­nal deve­lo­p­ment and com­mu­ni­ca­tion, as well as a start-up coach.

“I am very plea­sed that Ms. Lep­pert will be con­tri­bu­ting her busi­ness expe­ri­ence,” said Martin Lohse, CEO of ISAR Bioscience, wel­co­ming the new mem­ber to the super­vi­sory board. ”She will pro­vide important impe­tus for our eco­no­mic development.”